[--[65.84.65.76]--]
AUROPHARMA
AUROBINDO PHARMA LTD

1026.4 -1.69 (-0.16%)

Related News for AUROPHARMA

Buy Aurobindo Pharma, target price Rs 1160: Axis Securities

 23 Feb 09:42 AM

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2023.

Buy Aurobindo Pharma, target price Rs 1100: ICICI Securities

 24 Nov 11:41 AM

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 60471.79 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tablets

 12 Jul 06:28 PM

Aurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health regulator for generic Sevelamer hydrochloride tablets used to control serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The approval granted by the USFDA to make and market Sevelamer hydrochloride is for tablets of strengths 400 mg and 800 mg, Aurobindo Pharma said.

US FDA uncovers fresh faults at India's second-biggest drugmaker Aurobindo Pharma

 30 Jun 07:00 AM

Auditors uncovered “deficient” manufacturing equipment cleaning and storage controls during a visit last month to an Aurobindo Pharma Ltd. facility in Anakapalli, eastern India, according to a FDA report obtained by Bloomberg News through a Freedom of Information Act request.

Buy Aurobindo Pharma, target price Rs 564: BNP Paribas

 23 Nov 08:55 AM

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 26997.12 Crore) operating in Pharmaceuticals sector.

Accumulate Aurobindo Pharma, target price Rs 550: Prabhudas Lilladher

 17 Nov 10:03 AM

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28151.42 Crore) operating in Pharmaceuticals sector.

Buy Aurobindo Pharma, target price Rs 600: Centrum Broking

 16 Nov 09:22 AM

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28842.83 Crore) operating in Pharmaceuticals sector.

Sell Aurobindo Pharma, target price Rs 485: Religare Broking

 20 Sep 08:54 AM

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2022.

Hold Aurobindo Pharma, target price Rs 630: Axis Securities

 23 Aug 11:49 AM

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 32633.85 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma arm gets final US FDA nod for Vasopressin injection

 16 Aug 12:04 PM

New Delhi, Aug 16 (PTI) Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator for its generic version of Vasopressin injection.